Risk factors associated with short-term post-treatment outcomes of clinical mastitis

Journal of Dairy Science

Volumn 94, Issue 7, 2011, Pages 3397-3410

  Pinzon Sanchez C ^a   Ruegg, P L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Dairy; Mastitis; Milk quality; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE MASTITIS; CATTLE; CELL COUNT; CYTOLOGY; FEMALE; HOSPITALIZATION; MICROBIOLOGY; MILK; RECURRENT DISEASE; RISK FACTOR; TIME; TREATMENT OUTCOME; UDDER; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; CEPHALOSPORINS; FEMALE; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WISCONSIN;

ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA; NEGIBACTERIA; POSIBACTERIA; SERRATIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE;

EID: 79959339143     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2010-3925     Document Type: Article

References (41)

1. Andersen S., Dohoo I.R., Olde Riekerink R., Stryhn H. Diagnosing intramammary infections: Evaluating expert opinions on the definition of intramammary infection using conjoint analysis. J. Dairy Sci. 2010, 93:2966-2975. Mastitis Research Workers' Conference.
2. Apparao M.D., Ruegg P.L., Lago A., Godden S., Bey R., Leslie K. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium. J. Dairy Sci. 2009, 92:2589-2597.
3. Bar D., Gröhn Y.T., Bennett G., Gonzalez R.N., Hertl J.A., Schulte H.F., Tauer L.W., Welcome F.L., Schukken Y.H. Effect of repeated episodes of generic clinical mastitis on milk yield in dairy cows. J. Dairy Sci. 2007, 90:4643-4653.
4. Barkema H.W., Schukken Y.H., Zadoks R.N. Invited review: The role of cow pathogen and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 2006, 89:1877-1895.
5. Bowman G.L., Hueston W.D., Boner G.J., Hurley J.J., Andreas J.E. Serratia liquefaciens mastitis in a dairy herd. J. Am. Vet. Med. Assoc. 1986, 189:913-915.
6. Bradley A.J., Green M.J. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. J. Dairy Sci. 2009, 92:1941-1953.
7. Constable P.D., Morin D.E. Treatment of clinical mastitis using antimicrobial susceptibility profiles for treatment decisions. Vet. Clin. North Am. Food Anim. Pract. 2003, 19:139-155.
8. de Haas Y., Veerkamp R.F., Barkema H.W., Gröhn Y.T., Schukken Y.H. Associations between pathogen-specific cases of clinical mastitis and somatic cell count patterns. J. Dairy Sci. 2004, 87:95-105.
9. Deluyker H.A., Van Oye S.N., Boucher J.F. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J. Dairy Sci. 2005, 88:604-614.
10. Dinsmore R.P., English P.B., Gonzalez R.N., Sears P.M. Use of augmented cultural techniques in the diagnosis of the bacterial cause of clinical bovine mastitis. J. Dairy Sci. 1992, 75:2706-2712.
11. Erskine R.J., Wager S., DeGraves F.J. Mastitis therapy and pharmacology. Vet. Clin. North Am. Food Anim. Pract. 2003, 19:109-138.
12. Gröhn Y.T., Eicker S.W., Ducrocq V., Hertl J.A. Effect of disease on the culling of Holstein dairy cows in New York State. J. Dairy Sci. 1998, 81:966-978.
13. Gröhn Y.T., González R.N., Wilson D.J., Hertl J.A., Bennett G., Schulte H., Schukken Y.H. Effect of pathogen-specific clinical mastitis on herd life in two New York State dairy herds. Prev. Vet. Med. 2005, 71:105-125.
14. Gröhn Y.T., Wilson D.J., González R.N., Hertl J.A., Schulte H., Bennett G., Schukken Y.H. Effect of pathogen-specific clinical mastitis on milk yield in dairy cows. J. Dairy Sci. 2004, 87:3358-3374.
15. Guterbock W.M., Van Eenennaam A.L., Anderson R.J., Gardner I.A., Cullor J.S., Holmberg C.A. Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. J. Dairy Sci. 1993, 76:3437-3444.
16. Hadley G.L., Wolf C.A., Harsh S.B. Dairy cattle culling patterns, explanations, and implications. J. Dairy Sci. 2006, 89:2286-2296.
17. Hill A.E., Green A.L., Wagner B.A., Dargatz D.A. Relationship between herd size and annual prevalence of and primary antimicrobial treatments for common diseases on dairy operations in the United States. Prev. Vet. Med. 2009, 88:264-277.
18. Hoe F.G.H., Ruegg P.L. Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J. Am. Vet. Med. Assoc. 2005, 227:1461-1468.
19. Hogan J., Smith K.L. Coliform mastitis. Vet. Res. 2003, 34:507-519.
20. Houben E.H.P., Dijkhuizen A.A., Van Arendonk J.A.M., Huirne R.B.M. Short- and long-term production losses and repeatability of clinical mastitis in dairy cattle. J. Dairy Sci. 1993, 76:2561-2578.
21. Lago, J. A. 2009. Efficacy of on-farm programs for the diagnosis and selective treatment of clinical and subclinical mastitis in dairy cattle. PhD Dissertation. University of Minnesota, Minneapolis.
22. Makovec J.A., Ruegg P.L. Results of milk samples submitted for microbiological examination in Wisconsin from 1994 to 2001. J. Dairy Sci. 2003, 86:3466-3472.
23. McDougall S., Arthur D.G., Bryan M.A., Vermunt J.J., Weir A.M. Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antimicrobials. N. Z. Vet. J. 2007, 55:161-170.
24. Melchior M.B., Vaarkamp H., Fink-Gremmels J. Biofilms: A role in recurrent mastitis infections?. Vet. J. 2006, 171:398-407.
25. Milne M.H., Biggs A.M., Barrett D.C., Young F.J., Doherty S., Innocent G.T., Fitzpatrick J.L. Treatment of persistent intramammary infections with Streptococcus uberis in dairy cows. Vet. Rec. 2005, 157:245-250.
26. Laboratory Handbook on Bovine Mastitis 1999, NMC, National Mastitis Council, Verona, WI.
27. Nyman A.K., Emanuelson U., Persson Waller K. How may cow factors influence the long term success of antimicrobial treatment of clinical mastitis? Mastitis Research into Practice. Proceedings of the 5th IDF Mastitis Conference 2010.
28. Owens W.E., Watts J.L., Boddie R.L., Nickerson S.C. Antibiotic treatment of mastitis: Comparison of intramammary and intramammary plus intramuscular therapies. J. Dairy Sci. 1988, 71:3143-3147.
29. Palta M. Quantitative Methods on Population Health: Extensions of Ordinary Regression 2003, John Wiley and Sons, Hoboken, NJ.
30. Pol M., Ruegg P.L. Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin. J. Dairy Sci. 2007, 90:249-261.
31. Pyörälä S.H.K., Pyörälä E.O. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). J. Am. Vet. Med. Assoc. 1998, 212:407-412.
32. Roberson J.R., Warnick L.D., Moore G. Mild to moderate clinical mastitis: Efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. J. Dairy Sci. 2004, 87:583-592.
33. SAS Institute. 2008. SAS/STAT User's Guide. Version 9.2. SAS Inst. Inc., Cary, NC.
34. Schukken Y.H., Hertl J., Bar D., Bennett G.J., Gonzalez R.N., Rauch B.J., Santisteban C., Schulte H.F., Tauer L., Welcome F.L., Gröhn Y.T. Effects of repeated gram-positive and gram-negative clinical mastitis episodes on milk yield loss in Holstein dairy cows. J. Dairy Sci. 2009, 92:3091-3105.
35. Sears P.M., Gonzalez R.N., Wilson D.J., Han H.R. Procedures for mastitis diagnosis and control. Vet. Clin. North Am. Food Anim. Pract. 1993, 9:445-468.
36. Silva B.O., Caraviello D.Z., Rodrigues A.C., Ruegg P.L. Evaluation of Petrifilm for the isolation of Staphylococcus aureus from milk samples. J. Dairy Sci. 2005, 88:3000-3008.
37. Smith K.L., Todhunter D.A., Schoenberger P.S. Environmental mastitis: Cause, prevalence, prevention. J. Dairy Sci. 1985, 68:1531-1553.
38. Sol J., Sampimon O.C., Barkema H.W., Schukken Y.H. Factor associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 2000, 83:278-284.
39. Sol J., Sampimon O.C., Snoep J.J., Schukken Y.H. Factors associated with bacteriological cure during lactation after therapy for subclinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 1997, 80:2803-2808.
40. Steeneveld W., Hogeveen H., Barkema H.W., Van den Broek J., Huirne R.B.M. The influence of cow factors on the incidence of clinical mastitis in dairy cows. J. Dairy Sci. 2008, 91:1391-1402.
41. Wenz J.R., Garry F.B., Lombard J.E., Elia R., Prentice D., Dinsmore R.P. Short communication: Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle. J. Dairy Sci. 2005, 88:3496-3499.